Publicaciones en colaboración con investigadores/as de Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (1)

2019

  1. P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1